Cardiac safety profile of patients receiving high cumulative doses of pegylated-liposomal doxorubicin: use of left ventricular ejection fraction is of unproven value

2017 ◽  
Vol 80 (4) ◽  
pp. 787-798 ◽  
Author(s):  
Keith M. Skubitz ◽  
Anne H. Blaes ◽  
Suma H. Konety ◽  
Gary S. Francis
Keyword(s):  
Left Ventricular Ejection Fraction ◽  
Ejection Fraction ◽  
Safety Profile ◽  
Liposomal Doxorubicin ◽  
Pegylated Liposomal Doxorubicin ◽  
Left Ventricular ◽  
Ventricular Ejection ◽  
Left Ventricular Ejection ◽  
Cardiac Safety ◽  
Ventricular Ejection Fraction

Predictors of renal dysfunction in patients with chronic heart failure and reduced left ventricular ejection fraction

2018 ◽  
Vol 0 (3) ◽  
pp. 36-40
Author(s):  
L. G. Voronkov ◽  
G. E. Dudnik ◽  
A. V. Liashenko ◽  
T. I. Gavrilenko ◽  
L. S. Mkhitaryan ◽  
...  
Keyword(s):  
Heart Failure ◽  
Chronic Heart Failure ◽  
Left Ventricular Ejection Fraction ◽  
Ejection Fraction ◽  
Renal Dysfunction ◽  
Left Ventricular ◽  
Ventricular Ejection ◽  
Left Ventricular Ejection ◽  
Ventricular Ejection Fraction
Sign in / Sign up

Export Citation Format

Share Document